Investigating nano-based pain relief methods using human nerve cells
Validation of Pre-Clinical Nano-Based Analgesics in Cells From Dorsal Root Ganglia
This study is looking at nerve cells from patients with spinal tumors to see if new nano-based pain relief methods can help treat nerve pain better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 8 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT04533919 on ClinicalTrials.gov |
What this trial studies
This study focuses on the collection of dorsal root ganglia samples from patients undergoing surgery for spinal tumors to explore the potential of nano-based analgesics for treating neuropathic pain. By analyzing these human nerve cells, researchers aim to identify mechanisms and therapeutics that could lead to safer and more effective pain management strategies. The study is observational and does not involve any direct treatment interventions, relying instead on biospecimen collection for future research.
Who should consider this trial
Good fit: Ideal candidates for this study are patients scheduled for surgery to remove spinal tumors.
Not a fit: Patients not undergoing surgery for spinal tumors may not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to improved pain management options for patients suffering from neuropathic pain.
How similar studies have performed: While this approach is innovative, similar studies exploring pain management through cellular mechanisms have shown promise, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: ---All patients undergoing surgery to resect spinal tumors Exclusion Criteria: ---None
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Andrew J Shepherd — M.D. Anderson Cancer Center
- Study coordinator: Andrew J. Shepherd
- Email: ajshepherd@mdanderson.org
- Phone: 713-745-7959
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.